Top Startup and Tech Funding News – December 22, 2025
Nickie Louise
Posted On December 22, 2025
It’s Monday, December 22, 2025, and we’re back with today’s top startup and tech funding news spanning AI platforms, gene therapy, climate tech, and enterprise cybersecurity. From secure AI verification and hydrogen-powered aviation to no-code development and HSA-integrated wellness, today’s capital inflows spotlight the expanding role of intelligent systems in banking, biotech, and security.
Lovable led the day with a $330 million Series B to advance its natural language–based software creation tools. In comparison, Erebor Bank secured $350 million to build a crypto-native banking infrastructure, while ZeroAvia’s $150 million Series D signals surging interest in zero-emission commercial flight. Meanwhile, platforms such as Ciphero, FINNY, and Red Queen Bio are pioneering secure AI adoption, financial automation, and biosecurity protocols across sensitive sectors.
Today’s activity underscores how ambient AI—from predictive neuroscience and hydrogen propulsion to generative compliance—is reshaping critical workflows across finance, defense, and health, marking a pivotal shift toward human-machine systems engineered for trust, resilience, and adaptability.
Tech Funding News
Funding Highlights
-
Lovable raised $330M Series B for AI-powered no-code software development.
-
Erebor Bank secured $350M Series D for crypto-native banking services.
-
ZeroAvia raised a $150M Series D round to scale its hydrogen-electric aviation engines.
-
SanegeneBio closed $110M Series B for RNAi-based gene therapies.
-
Neurable raised a $35M Series A for EEG-integrated brain-health wearables.
-
Truemed brought in $34M Series A to enable HSA spending on wellness products.
-
FINNY secured $17M Series A to automate prospecting for financial advisors.
-
Red Queen Bio raised $15M Seed to develop AI-driven biosecurity safeguards.
-
Gambit Cyber raised $3.4M Seed for AI-native threat exposure management.
-
Ciphero closed $2.5M Pre-Seed to secure enterprise AI with real-time validation.
Investor Activity
Today’s funding drew participation from top venture and strategic firms—from Andreessen Horowitz and CapitalG to OpenAI and Breakthrough Energy—powering infrastructure layers that operationalize AI, bio-intelligence, and critical system defense. As the year nears its close, investor focus remains firmly fixed on startups building trusted intelligence into health, financial, and security architectures.
Here’s the full breakdown of December 22’s most significant startup and tech fundings.
Lovable Raises $330M in Series B Funding to Power No-Code AI Platform
Lovable, a Swedish AI startup, announced a $330 million Series B round at a $6.6 billion valuation. The round was led by Google’s CapitalG and Menlo Ventures’ Anthology fund, with strategic and venture investors including Salesforce Ventures, Databricks Ventures, Atlassian Ventures, Khosla Ventures, DST Global, EQT Growth, Kinship Ventures, Accel, Creandum, and Evantic. Lovable’s platform enables “builders” (product managers, marketers, etc.) to rapidly create production-grade software without writing code, using AI-driven interfaces.
The AI startup reports more than 25 million projects created on its platform in the past year, with enterprise users such as Klarna and Deutsche Telekom already leveraging Lovable to accelerate development cycles. This new infusion will help Lovable scale its app-building tools and meet surging demand for no-code AI solutions in both consumer and corporate settings.
Funding Details:
-
Startup: Lovable
-
Investors: CapitalG (lead), Menlo Ventures Anthology (lead), Salesforce Ventures, Databricks Ventures, Atlassian Ventures, HubSpot Ventures, Khosla Ventures, DST Global, EQT Growth, Kinship Ventures, Accel, Creandum, Evantic
-
Amount Raised: $330 million
-
Total Raised: $330 million
-
Funding Stage: Series B
-
Funding Date: December 22, 2025
Erebor Bank Secures $350M at $4.35B Valuation for Crypto-Focused Banking
Erebor Bank, a Silicon Valley startup serving crypto, AI, and defense firms, secured $350 million in fresh funding at an implied $4.35 billion valuation. The round was led by Lux Capital, with participation from venture backers Founders Fund, 8VC, and others. The $350 million infusion follows Erebor’s recent FDIC approval, enabling it to expand its suite of crypto-friendly banking services.
Erebor plans to use the new capital to hire talent and deepen its technology platform, supporting its bid to become a full-featured bank for emerging-tech companies. The funding will accelerate global expansion and bolster compliance efforts as Erebor moves toward launching deposit and loan products for fintech and crypto enterprises.
Funding Details:
-
Startup: Erebor Bank
-
Investors: Lux Capital (lead), Founders Fund, 8VC, Haun Ventures
-
Amount Raised: $350 million
-
Total Raised: $350 million
-
Funding Stage: Series D
-
Funding Date: December 22, 2025
ZeroAvia Secures New Funding to Advance Hydrogen-Electric Aviation
ZeroAvia, an electric aviation startup developing hydrogen fuel-cell engines, announced additional funding led by climate-focused investors on Dec. 22. The round, part of a larger $150 million Series D effort, was led by Barclays Climate Ventures, with Breakthrough Energy Ventures, Ecosystem Integrity Fund, Horizons Ventures, Summa Equity, and AP Ventures as co-investors, and participation from the Russian National Wealth Fund and Scotland’s National Investment Bank.
ZeroAvia will use the funding to extend its runway and accelerate certification of its ZA600 engine, which targets 10–20 seat regional aircraft. The capital will expand its production facilities and partnerships, allowing the startup to further its goal of deploying hydrogen-electric powertrains for commercial and defense aviation.
Funding Details:
-
Startup: ZeroAvia
-
Investors: Barclays Climate Ventures, Breakthrough Energy Ventures, Ecosystem Integrity Fund, Horizons Ventures, Summa Equity, AP Ventures (co-leads); National Wealth Fund, Scottish National Investment Bank
-
Amount Raised: $150 million
-
Total Raised: $150 million
-
Funding Stage: Series D
-
Funding Date: December 22, 2025
SanegeneBio Raises $110M in Series B Funding for Gene Therapy Pipeline
SanegeneBio, a Boston-based biotech developing RNAi gene therapies, closed a Series B of over $110 million on Dec. 22. The undisclosed lead investor was joined by a broad syndicate including China’s Sino Biopharm, Legend Capital, Vivo Capital, Invus, SymBiosis, Guofa Capital, TruMed, and Lake Bleu Capital. The round also featured a strategic investment from Eli Lilly.
SanegeneBio will use the funds to advance its proprietary LEAD RNAi delivery platform and move multiple clinical-stage programs toward registrational studies across autoimmune, cardiovascular, metabolic, and obesity indications. The financing positions the company to accelerate late-stage trials globally and expand its pipeline of RNAi therapeutics for serious diseases.
Funding Details:
-
Startup: SanegeneBio
-
Investors: (Industrial lead undisclosed), Sino Biopharm, Legend Capital, Vivo Capital, Invus, SymBiosis, Guofa Capital, TruMed, Lake Bleu Capital, Eli Lilly (strategic)
-
Amount Raised: $110 million
-
Total Raised: $110 million
-
Funding Stage: Series B
-
Funding Date: December 22, 2025
Neurable Lands $35M in Series A Funding for EEG Brain-Health Wearables
Neurable, a Boston neurotech startup, announced a $35 million Series A round on Dec. 22. The financing was led by Spectrum Moonshot Fund, bringing Neurable’s total fundraising to $65 million. Neurable’s wearable EEG devices integrate brain monitoring into products like headphones and VR gear, enabling users to track cognitive states and brain health.
The new capital will help Neurable scale its hardware and AI algorithms, accelerating product development for consumer mental wellness markets. The company aims to make continuous brain metrics as routine as tracking sleep or heart rate, and the funding will support expansion into emerging neuro-insights applications.
Funding Details:
-
Startup: Neurable
-
Investors: Spectrum Moonshot Fund (lead)
-
Amount Raised: $35 million
-
Total Raised: $65 million
-
Funding Stage: Series A
-
Funding Date: December 22, 2025
Truemed Raises $34M in Series A Funding for HSA-Based Wellness Platform
Truemed, a California wellness fintech startup founded by Justin Mares, secured a $34 million Series A round led by Andreessen Horowitz. The funding signals investor confidence in Truemed’s mission to help consumers use tax-advantaged HSA funds for wellness products. Truemed’s platform allows users to purchase items such as exercise equipment, saunas, and supplements using their health savings accounts.
The new funding will fuel the growth of Truemed’s technology and expand its partnerships, enabling faster user acquisition. Truemed plans to use the capital to enhance its consumer app and accelerate its efforts to integrate preventive health products with everyday medical spending.
Funding Details:
-
Startup: Truemed
-
Investors: Andreessen Horowitz (lead)
-
Amount Raised: $34 million
-
Total Raised: $34 million
-
Funding Stage: Series A
-
Funding Date: December 22, 2025
FINNY Raises $17M in Series A Funding for AI-Driven Advisor Prospecting
FINNY, a New York-based fintech startup, announced a $17 million Series A round on Dec. 22 led by Venrock. The funding attracted heavyweight investors, including former Vanguard CEO William McNabb and venture firms Y Combinator, Maple VC, and Crossbeam Ventures. FINNY’s AI-powered platform helps financial advisors identify and convert high-value prospects by analyzing thousands of data signals.
The company’s tool automates outreach and continuously learns which strategies yield the best client conversions. With the new capital, FINNY will expand its engineering and data science teams to accelerate product enhancements and market expansion, building on more than $20 million raised to date.
Funding Details:
-
Startup: FINNY
-
Investors: Venrock (lead), William McNabb, Y Combinator, Maple VC, Crossbeam Ventures
-
Amount Raised: $17 million
-
Total Raised: $20 million+
-
Funding Stage: Series A
-
Funding Date: December 22, 2025
Gambit Cyber Raises $3.4M in Seed Funding for AI-Native Threat Management
Dutch cybersecurity startup Gambit Cyber announced a $3.4 million seed round led by Expeditions, with participation from Bitdefender’s Voyager Ventures. Gambit’s flagship product, KnightGuard, is an AI-native threat exposure management platform that identifies critical vulnerabilities and automates remediation workflows.
Enterprises in the finance, telecom, and critical infrastructure sectors already use KnightGuard to identify exploitable security gaps. The new funding will expand Gambit’s engineering team, deploy additional AI agents within the platform, and accelerate global sales and partnerships across Europe, the UAE, and Asia-Pacific.
Funding Details:
-
Startup: Gambit Cyber
-
Investors: Expeditions (lead), Bitdefender Voyager Ventures
-
Amount Raised: $3.4 million
-
Total Raised: $3.4 million
-
Funding Stage: Seed
-
Funding Date: December 22, 2025
Ciphero Raises $2.5M in Pre-Seed Funding to Secure Enterprise AI
Ciphero, a Silicon Valley startup founded by veterans of Mozilla and Fakespot, closed a $2.5 million pre-seed round on Dec. 22. The round was co-led by Sovereign’s Capital and Chingona Ventures. Ciphero is building the first enterprise “AI verification layer” that dynamically validates all AI interactions (human or agent) to prevent data leaks and compliance violations.
The funding will allow Ciphero to expand its team and integrate its verification platform into corporate environments, helping enterprises adopt generative AI securely while safeguarding sensitive information.
Funding Details:
-
Startup: Ciphero
-
Investors: Sovereign’s Capital (co-lead), Chingona Ventures (co-lead)
-
Amount Raised: $2.5 million
-
Total Raised: $2.5 million
-
Funding Stage: Pre-seed
-
Funding Date: December 22, 2025
Red Queen Bio Raises $15M in Seed Funding for AI-Driven Biosecurity
Red Queen Bio, a new AI-powered biosecurity startup spun out of HelixNano, secured a $15 million seed round led by OpenAI. Red Queen Bio will use the proceeds to develop AI tools that detect and defend against biologically engineered threats. Its mission is to build open, scalable safeguards against the misuse of biotechnology – for example, preventing the creation of novel pathogens through AI.
As a public-benefit corporation, Red Queen plans to collaborate with leading labs worldwide, using advanced modeling and lab automation to stay ahead of emerging bio-risks.
Funding Details:
-
Startup: Red Queen Bio
-
Investors: OpenAI (lead), other mission-aligned investors (undisclosed)
-
Amount Raised: $15 million
-
Total Raised: $15 million
-
Funding Stage: Seed
-
Funding Date: December 22, 2025
Tech Funding Summary Table
| Startup | Investors (Lead and notable investors) | Amount Raised | Total Raised | Funding Stage | Funding Date |
|---|---|---|---|---|---|
| Lovable | CapitalG (lead), Menlo Anthology (lead), Salesforce Ventures, Databricks Ventures, Atlassian Ventures, HubSpot Ventures, Khosla Ventures, DST Global, EQT Growth, Kinship Ventures, Accel, Creandum, Evantic | $330 M | $330 M | Series B | Dec 22, 2025 |
| Erebor Bank | Lux Capital (lead), Founders Fund, 8VC, Haun Ventures | $350 M | $350 M | Series D | Dec 22, 2025 |
| ZeroAvia | Barclays Climate Ventures, Breakthrough Energy Ventures, Ecosystem Integrity Fund, Horizons Ventures, Summa Equity, AP Ventures, National Wealth Fund, Scottish Nat’l Investment Bank | $150 M | $150 M | Series D | Dec 22, 2025 |
| SanegeneBio | (Lead undisclosed), Sino Biopharm, Legend Capital, Vivo Capital, Invus, SymBiosis, Guofa Capital, TruMed, Lake Bleu Capital, Eli Lilly (strategic) | $110 M | $110 M | Series B | Dec 22, 2025 |
| Neurable | Spectrum Moonshot Fund (lead) | $35 M | $65 M | Series A | Dec 22, 2025 |
| Truemed | Andreessen Horowitz (lead) | $34 M | $34 M | Series A | Dec 22, 2025 |
| FINNY | Venrock (lead), William McNabb, Y Combinator, Maple VC, Crossbeam Ventures | $17 M | ~$20 M | Series A | Dec 22, 2025 |
| Gambit Cyber | Expeditions (lead), Bitdefender Voyager Ventures | $3.4 M | $3.4 M | Seed | Dec 22, 2025 |
| Ciphero | Sovereign’s Capital (co-lead), Chingona Ventures (co-lead) | $2.5 M | $2.5 M | Pre-seed | Dec 22, 2025 |
| Red Queen Bio | OpenAI (lead), other mission-aligned investors (undisclosed) | $15 M | $15 M | Seed | Dec 22, 2025 |
Trending Now
Top Startup and Tech Funding News – December 2, 2025
